SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain

BACKGROUND: Neuropathic pain is experienced worldwide by patients suffering from nerve injuries, infectious or metabolic diseases or chemotherapy. However, the treatment options are still limited because of low efficacy and sometimes severe side effects. Recently, the deficiency of FKBP51 was shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Wedel, Saskia, Mathoor, Praveen, Rauh, Oliver, Heymann, Tim, Ciotu, Cosmin I., Fuhrmann, Dominik C., Fischer, Michael J. M., Weigert, Andreas, de Bruin, Natasja, Hausch, Felix, Geisslinger, Gerd, Sisignano, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552419/
https://www.ncbi.nlm.nih.gov/pubmed/36217203
http://dx.doi.org/10.1186/s12974-022-02615-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552419/
https://www.ncbi.nlm.nih.gov/pubmed/36217203
http://dx.doi.org/10.1186/s12974-022-02615-7

Ejemplares similares